OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...

A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...

February 18, 2010 — Low doses of platelets given prophylactically led to a decreased number of platelets transfused per patient but an increased number of transfusions given, according to the results ...

THE hemorrhagic tendency of thrombocytopenic animals can be controlled temporarily by transfusions of fresh platelet concentrates. 1,2 The clinical value of platelet transfusions has previously been ...

In a new paper, researchers from University Hospitals (UH) detail how they used data via a dashboard to decrease the use of packed red-blood cell (pRBC) transfusions and platelets with an increase in ...

Platelet transfusions play a major role in the management of thrombocytopenia in hematological and oncologic patients. However, a proportion of these patients become refractory to the transfusion of ...